PRICE HISTORY.
Use the left and right arrow keys to inspect dated observations. Home selects the first observation and End selects the latest.
Key numbers
Published fundamentals and the date each figure was recorded.
East India Pharmaceutical Works Limited is a pharmaceutical manufacturer established in 1936. It operates WHO-GMP compliant manufacturing facilities at Sarsuna and Durgapur and sells into domestic and select international markets. Its product portfolio includes analgesics, antibiotics, hematinics, vitamins, gastrointestinal medicines and Ayurvedic formulations. The FY25 management report says its strategy included expanding marketing reach and launching products in multivitamin and paediatric segments. It reported stable domestic revenue from demand for modern and Ayurvedic products, increased capacity utilisation at its Durgapur bulk-drug unit, and digital engagement with healthcare professionals. The company says it focuses on product quality, regulatory compliance and cost optimisation through backward integration of APIs. Its operating system includes ERP across inventory, production and sales, GMP-compliant manufacturing and quality-assurance protocols, and automated management information systems. The company reports employing more than 1,500 people across plant operations, quality assurance, marketing and management.
About this company
East India Pharmaceutical Works Limited is one of India's oldest pharmaceutical companies, incorporated in 1936 and headquartered in Kolkata, West Bengal. Over more than eight decades, the company has built a presence in the domestic healthcare market through the manufacturing and marketing of a broad range of formulations spanning analgesics, haematinics, digestive enzymes, eye-care products, anti-infectives, and select Ayurvedic and personal-care lines. Its operations combine in-house production with contract manufacturing under a loan-licensing arrangement, supported by facilities in Sarsuna (Kolkata) and Durgapur. The company is often discussed among unlisted names because of its long operating history, established product brands, and a nationwide field and distribution network. As an unlisted security, its shares are not traded on a stock exchange, so they typically carry higher risk and materially lower liquidity than listed equities, and any quoted price is indicative rather than exchange-determined. This information is provided for general awareness only and is not investment advice.
COMPANY REGISTRY · ON FILE
THE CREW · BOARD & MANAGEMENT
COMMON QUESTIONS.
Is East India Pharmaceutical Works Limited listed on the stock exchange?+
No. As of 2 September 2026, East India Pharmaceutical Works Limited is an unlisted company whose shares trade over-the-counter; it would list only if and when it completes an IPO.
What is the East India Pharmaceutical Works Limited unlisted share price?+
As of 2 September 2026, the indicative unlisted share price of East India Pharmaceutical Works Limited is ₹79 per share. This is an over-the-counter reference price, not a stock-exchange quote.
What indicative minimum amount is displayed for East India Pharmaceutical Works Limited unlisted shares?+
The displayed unit count is 130 share(s); at the indicative price of about ₹79, the displayed amount is approximately ₹10,270. This is a display convention, not evidence of inventory, an order minimum or a quote.
What is the ISIN of East India Pharmaceutical Works Limited?+
The recorded ISIN of East India Pharmaceutical Works Limited is INE254X01017. An ISIN is a 12-character security identifier. Verify it against the issuer and the relevant depository record before using it for any transfer or documentation.
Is trading in East India Pharmaceutical Works Limited unlisted shares legal in India?+
Unlisted shares can be transferred off-market in India, but the legal, tax and compliance position depends on the security, parties, documents and current rules. Verify the intermediary, issuer restrictions and applicable requirements before proceeding.
Is there a lock-in period for unlisted shares?+
A post-listing lock-in may apply under the rules in force at the time. The period and any exemptions can depend on the holder and acquisition, so check the current regulation and the issuer's offer documents rather than relying on a generic period.
Do you guarantee returns?+
No. Unlisted shares carry higher risk and lower liquidity than listed shares. Returns depend on company performance, market conditions and future listing outcomes. This is information only, not investment advice.